Migraine Study UBR-MD-02


Have your previous Migraine medications failed you?

You may qualify for a research study (Clinical Trial Phase 3) if you:

  • Have 2-8 moderate/sever migraine attacks per month
  • Have had migraines for at least a year, and
  • Between 18 -75 years of age

Qualified participants may receive:

  • Study related care and examination at no cost
  • Compensation for time & travel

Please use the form below at the bottom of the website to receive alerts from our clinic or use the contact form here.

This study can last from 1-4 months to treat a single migraine attack.  Participants must have 2-8 migraine attacks per month, and can be on preventive migraine treatment if they are stable over the last 2 months. Participants will have the option of rolling into the 18 month long-term study.

Clinical trials are part of clinical research and at the heart of all medical advances. Clinical trials look at new ways to prevent, detect, or treat disease.

The goal of clinical trials is to determine if a new test or treatment works and is safe. The advanced studies done during clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. If you are experiencing migraines or know a friend or family with migraine issues, please refer them to our clinic.

Please visit the FDA website for more details on this trial –¬†https://clinicaltrials.gov/ct2/show/NCT02867709

This website is for informational purposes only. Please dial 911 for emergency.

Torticollis Research Study
This is default text for notification bar